IPCA LABORATORIES LTD. - 524494 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
We are re-filing herewith our Press Release filed on 24th April, 2023 alongwith the covering letter as required.26-04-2023
26-04-2023
Hold IPCA Laboratories; target of Rs 790: Sharekhan
Sharekhan recommended Hold rating on IPCA Laboratories with a target price of Rs 790 in its research report dated April 25, 2023.26-04-2023
IPCA LABORATORIES LTD. - 524494 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyIPCA LABORATORIES LTD. 2CIN NO.L24239MH1949PLC007837 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 559.33 4Highest Credit Rating during the previous FY AA+ 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)INDIA RATINGS AND RESEARCH PVT. LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. YES Name of the Company Secretary: Harish P Kamath Designation: Corporate Counsel and Company Secretary EmailId: [email protected] Name of the Chief Financial Officer: Ajit Kumar Jain Designation: Chief Financial Officer EmailId: [email protected] Date: 25/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.25-04-2023
Ipca Labs at 52-week low on plans to acquire stake in Unichem Labs at premium
Ipca Labs plans to acquire a 33.38 percent stake in Unichem Labs at Rs 400 per share, aggregating around Rs 1,034.06 crores.25-04-2023
IPCA-Unichem deal: Here are the key takeaways
Open offer price appears attractive for a slow growing business24-04-2023
IPCA LABORATORIES LTD. - 524494 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
We wish to inform you that a Conference Call to discuss our acquisition of 33.38% shareholding in Unichem Laboratories Ltd. will be held on Tuesday, 25th April, 2023 at 16.00 hrs IST.24-04-2023
IPCA LABORATORIES LTD. - 524494 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release - Acquisition of 33.38% of the paid-up equity share capital of Unichem Laboratories Ltd.24-04-2023
IPCA LABORATORIES LTD. - 524494 - Announcement under Regulation 30 (LODR)-Public Announcement-Open Offer
Public Announcement made to the public shareholders of M/s. Unichem Laboratories Ltd. (506690 on BSE: UNICHEMLAB on NSE)24-04-2023
IPCA LABORATORIES LTD. - 524494 - Announcement under Regulation 30 (LODR)-Acquisition
Acquisition of 33.38% of the paid-up equity share capital of Unichem Laboratories Ltd. (506690 on BSE: UNICHEMLAB on NSE)24-04-2023
IPCA LABORATORIES LTD. - 524494 - Board Meeting Outcome for Outcome Of The Board Meeting - Acquisition Of 33.38% Of The Paid-Up Equity Share Capital Of Unichem Laboratories Ltd. (506690 On BSE: UNICHEMLAB On NSE)
Outcome of the Board Meeting - Acquisition of 33.38% of the paid-up equity share capital of Unichem Laboratories Ltd. (506690 on BSE: UNICHEMLAB on NSE)24-04-2023